Erowid References Database
|
Verebey K, Alrazi J, Jaffe JH.
“The complications of 'ecstasy' (MDMA)”.
JAMA. 1988;259(11):1649-50.
|
|
Abstract
Drs Brown and Osterloh, in a recent letter in THE JOURNAL, reported a nearly fatal toxic reaction to 3,4-methylenedioxymethamphetamine (MDMA). The estimated dose of MDMA administered was 100 to 150mg and the blood levels, measured at one and two hours after hospital admission, were 6500 and 7000 ng/mL, respectively.
Before MDMA became a Schedule 1 drug on July 1, 1985, it was used in doses of 100 to 150 mg by some psychiatrists who claimed that it was effective as a psychotropic catalyst and a sensory disinhibitor; at these doses, no toxic effects were reported. (The experiment was performed on March 12, 1985, before the scheduling of MDMA and was carried out by one of us [J.A.] in partial requirement for the degree of Doctor of Physiology.) At that time, we carried out a controlled study of MDMA metabolism and disposition in a single patient. On the basis of that study, we believe that the dose used in the study by Drs Brown and Osterloh would have had to have been much higher to produce the reported blood levels of MDMA of 6500 to 7000 ng/mL.
|
| # |
| Submit Comment |
|
[
Cite HTML ]
